Yaxwer
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Yaxwer, covering 2025-09-08 to 2026-08-18. Get the full timeline:
Most recent: EMA Authorised: Yaxwer (denosumab) — Gedeon Richter Plc.
2 regulatory and trial events tracked for Yaxwer, covering 2025-09-08 to 2026-08-18. Get the full timeline:
Most recent: EMA Authorised: Yaxwer (denosumab) — Gedeon Richter Plc.